Fundraising FoxBill Rastetter
InvestorAdvisor at Illumina Ventures
Find your path to Bill
47 people in our graph can introduce you to Bill.
Each arrow is one introduction. Sign up to fill in the first one.
Ask Mark Mullaney to introduce you to Bill
You →Mark · together at Illumina Ventures →Bill
Ask Jamie Chen to introduce you to Bill
You →Jamie · 11 people · together at Illumina Ventures →Bill
Sign up to find every way you can get introduced to Bill
- Your email: the people you already email who know Bill
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with Bill
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
About
A biotechnology investor and industry veteran, Bill Rastetter served on Illumina's board for 17 years, including a decade as chairman, and holds board roles at companies including GRAIL, Neurocrine Biosciences, and Fate Therapeutics. He co-founded and chaired Receptos (sold to Celgene in 2015), led the merger forming Biogen Idec, co-invented the cancer therapy Rituxan at Idec Pharmaceuticals, and holds a PhD in Chemistry from Harvard.
Colleagues at Illumina Ventures
Frequently asked questions
- Who is Bill Rastetter?
- A biotechnology investor and industry veteran, Bill Rastetter served on Illumina's board for 17 years, including a decade as chairman, and holds board roles at companies including GRAIL, Neurocrine Biosciences, and Fate Therapeutics. He co-founded and chaired Receptos (sold to Celgene in 2015), led the merger forming Biogen Idec, co-invented the cancer therapy Rituxan at Idec Pharmaceuticals, and holds a PhD in Chemistry from Harvard.
- Where does Bill Rastetter work?
- Bill Rastetter is Advisor at Illumina Ventures.